{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:20:24Z","timestamp":1791116424843,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.suronc.2005.05.003","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T10:51:36Z","timestamp":1120301496000},"page":"91-104","source":"Crossref","is-referenced-by-count":9,"title":["Molecular changes in prostatic cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"S.R.J.","family":"Bott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.S.","family":"Shergill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/07853890109002068","article-title":"Molecular genetics of prostate cancer","volume":"33","author":"Elo","year":"2001","journal-title":"Annals of Medicine"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.suronc.2005.05.003_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0065-230X(08)60355-3","article-title":"Genetic basis and clonal evolution of human prostate cancer","volume":"68","author":"Kallioniemi","year":"1996","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/j.suronc.2005.05.003_bib4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archinte.1913.00070050063006","article-title":"Heredity with reference to carcinoma","volume":"12","author":"Wartin","year":"1913","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.1966.03870080050009","article-title":"Hereditary factors in cancer. Study of two large midwestern kindreds","volume":"117","author":"Lynch","year":"1966","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"15","key":"10.1016\/j.suronc.2005.05.003_bib8","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1073\/pnas.90.15.7351","article-title":"Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma","volume":"90","author":"Hogg","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pros.2990170409","article-title":"Family history and the risk of prostate cancer","volume":"17","author":"Steinberg","year":"1990","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5","article-title":"Concerning a familial association between breast cancer and both prostatic and uterine malignancies","volume":"34","author":"Thiessen","year":"1974","journal-title":"Cancer"},{"issue":"6858","key":"10.1016\/j.suronc.2005.05.003_bib11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/bmj.305.6858.855","article-title":"Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer","volume":"305","author":"Tulinius","year":"1992","journal-title":"British Medical Journal"},{"issue":"14","key":"10.1016\/j.suronc.2005.05.003_bib12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jnci\/84.14.1114","article-title":"Breast cancer risks in relatives of male breast cancer patients","volume":"84","author":"Anderson","year":"1992","journal-title":"Journal of the National Cancer Institute"},{"issue":"24","key":"10.1016\/j.suronc.2005.05.003_bib13","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/jnci\/86.24.1860","article-title":"Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer","volume":"86","author":"Sellers","year":"1994","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-5347(17)35617-3","article-title":"Hereditary prostate cancer: epidemiologic and clinical features","volume":"150","author":"Carter","year":"1993","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1086\/316916","article-title":"Genetics of prostate cancer: too many loci, too few genes","volume":"67","author":"Ostrander","year":"2000","journal-title":"American Journal of Human Genetics"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/302818","article-title":"A genome screen of multiplex sibships with prostate cancer","volume":"66","author":"Suarez","year":"2000","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/84808","article-title":"A candidate prostate cancer susceptibility gene at chromosome 17p","volume":"27","author":"Tavtigian","year":"2001","journal-title":"Nature Genetics"},{"issue":"5291","key":"10.1016\/j.suronc.2005.05.003_bib18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.274.5291.1371","article-title":"Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search","volume":"274","author":"Smith","year":"1996","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.suronc.2005.05.003_bib19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jnci\/89.13.955","article-title":"Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study","volume":"89","author":"Cooney","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"issue":"24","key":"10.1016\/j.suronc.2005.05.003_bib20","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/89.24.1893","article-title":"Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study","volume":"89","author":"Hsieh","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib21","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/301879","article-title":"Predisposing gene for early onset prostate cancer, localized on chromosome 1q42.2-43","volume":"62","author":"Berthon","year":"1998","journal-title":"American Journal of Human Genetics"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/301745","article-title":"Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign\/British Prostate Group UK Familial Prostate Cancer Study Collaborators","volume":"62","author":"Eeles","year":"1998","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/514853","article-title":"Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24\u201325","volume":"61","author":"McIndoe","year":"1997","journal-title":"American Journal of Human Genetics"},{"issue":"11","key":"10.1016\/j.suronc.2005.05.003_bib24","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/bjc.1998.703","article-title":"Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC\/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign\/British Prostate Group","volume":"78","author":"Dunsmuir","year":"1998","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.suronc.2005.05.003_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.pcan.4500279","article-title":"Genetic predisposition to prostate cancer","volume":"2","author":"Eeles","year":"1999","journal-title":"Prostate Cancer and Prostatic Disease"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib26","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1086\/302094","article-title":"Use of parents, sibs, and unrelated controls for detection of associations between genetic markers and disease","volume":"63","author":"Schaid","year":"1998","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/2477","article-title":"Evidence for a prostate cancer susceptibility locus on the X chromosome","volume":"20","author":"Xu","year":"1998","journal-title":"Nature Genetics"},{"issue":"15","key":"10.1016\/j.suronc.2005.05.003_bib28","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","article-title":"The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function","volume":"22","author":"Chamberlain","year":"1994","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/hmg\/4.4.523","article-title":"Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies","volume":"4","author":"Kazemi-Esfarjani","year":"1995","journal-title":"Human Molecular Genetics"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib30","first-page":"1194","article-title":"Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk","volume":"57","author":"Stanford","year":"1997","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/j.suronc.2005.05.003_bib31","first-page":"1937","article-title":"The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer","volume":"55","author":"Irvine","year":"1995","journal-title":"Cancer Research"},{"issue":"18","key":"10.1016\/j.suronc.2005.05.003_bib32","first-page":"5111","article-title":"Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China","volume":"60","author":"Hsing","year":"2000","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.suronc.2005.05.003_bib33","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1073\/pnas.94.7.3320","article-title":"The CAG repeat within the androgen receptor gene and its relationship to prostate cancer","volume":"94","author":"Giovannucci","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib34","first-page":"1626","article-title":"Association of SRD5A2 genotype and pathological characteristics of prostate tumors","volume":"60","author":"Jaffe","year":"2000","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib35","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/en.132.5.1952","article-title":"Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines","volume":"132","author":"Skowronski","year":"1993","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib36","first-page":"805","article-title":"Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells","volume":"54","author":"Peehl","year":"1994","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib37","first-page":"467","article-title":"Vitamin D and prostate cancer: a prediagnostic study with stored sera","volume":"2","author":"Corder","year":"1993","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"issue":"9","key":"10.1016\/j.suronc.2005.05.003_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1008923802001","article-title":"Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)","volume":"11","author":"Ahonen","year":"2000","journal-title":"Cancer Causes & Control"},{"issue":"18","key":"10.1016\/j.suronc.2005.05.003_bib39","first-page":"4108","article-title":"Association of prostate cancer with vitamin D receptor gene polymorphism","volume":"56","author":"Taylor","year":"1996","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib40","first-page":"305","article-title":"Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population","volume":"60","author":"Habuchi","year":"2000","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1098-2744(200001)27:1<18::AID-MC4>3.0.CO;2-O","article-title":"Vitamin D receptor polymorphisms and prostate cancer","volume":"27","author":"Blazer","year":"2000","journal-title":"Molecular Carcinogenesis"},{"issue":"8","key":"10.1016\/j.suronc.2005.05.003_bib42","first-page":"1620","article-title":"Association of prostate cancer with vitamin D receptor haplotypes in African-Americans","volume":"58","author":"Ingles","year":"1998","journal-title":"Cancer Research"},{"issue":"4 Suppl 1","key":"10.1016\/j.suronc.2005.05.003_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0090-4295(00)00942-0","article-title":"Prostate cancer prevention agent development: criteria and pipeline for candidate chemoprevention agents","volume":"57","author":"Nelson","year":"2001","journal-title":"Urology"},{"issue":"16","key":"10.1016\/j.suronc.2005.05.003_bib44","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jnci\/90.16.1225","article-title":"Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4","volume":"90","author":"Rebbeck","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"20","key":"10.1016\/j.suronc.2005.05.003_bib45","first-page":"5710","article-title":"Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect","volume":"60","author":"Habuchi","year":"2000","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib46","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/303096","article-title":"Association of HPC2\/ELAC2 genotypes and prostate cancer","volume":"67","author":"Rebbeck","year":"2000","journal-title":"American Journal of Human Genetics"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/labinvest.3780096","article-title":"Identification of genetic markers for prostatic cancer progression","volume":"80","author":"Alers","year":"2000","journal-title":"Laboratory Investigation"},{"issue":"5\u20136","key":"10.1016\/j.suronc.2005.05.003_bib48","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000019907","article-title":"Molecular biology of progression of prostate cancer","volume":"35","author":"Nupponen","year":"1999","journal-title":"European Urology"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib49","first-page":"1142","article-title":"Distinct regions of allelic loss on 13q in prostate cancer","volume":"56","author":"Cooney","year":"1996","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib50","first-page":"1058","article-title":"Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions","volume":"57","author":"Latil","year":"1997","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<175::AID-GCC1>3.0.CO;2-H","article-title":"Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer","volume":"24","author":"Li","year":"1999","journal-title":"Genes Chromosomes & Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pros.10038","article-title":"Refined mapping of allele loss at chromosome 10q23\u201326 in prostate cancer","volume":"50","author":"Leube","year":"2002","journal-title":"Prostate"},{"issue":"3\u20134","key":"10.1016\/j.suronc.2005.05.003_bib53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjc.6690087","article-title":"Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer","volume":"79","author":"Hugel","year":"1999","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib54","first-page":"495","article-title":"Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer","volume":"14","author":"Perinchery","year":"1999","journal-title":"International Journal of Oncology"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib55","first-page":"443","article-title":"CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker","volume":"6","author":"Lee","year":"1997","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib56","first-page":"531","article-title":"CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia","volume":"7","author":"Brooks","year":"1998","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"issue":"21","key":"10.1016\/j.suronc.2005.05.003_bib57","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1073\/pnas.82.21.7202","article-title":"Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties","volume":"82","author":"Mannervik","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.suronc.2005.05.003_bib58","first-page":"2727","article-title":"Molecular detection of prostate cancer in urine by GSTP1 hypermethylation","volume":"7","author":"Cairns","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0090-4295(01)01268-7","article-title":"DNA-based detection of prostate cancer in urine after prostatic massage","volume":"58","author":"Goessl","year":"2001","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3181\/00379727-216-44169","article-title":"Detoxication enzymes and chemoprevention","volume":"216","author":"Wilkinson","year":"1997","journal-title":"Proceedings for the Society of Experimental Biology and Medicine"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib61","first-page":"342","article-title":"Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization","volume":"55","author":"Visakorpi","year":"1995","journal-title":"Cancer Research"},{"issue":"14","key":"10.1016\/j.suronc.2005.05.003_bib62","first-page":"2959","article-title":"Allelic loss on chromosome 8p12\u201321 in microdissected prostatic intraepithelial neoplasia","volume":"55","author":"Emmert-Buck","year":"1995","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<219::AID-IJC9>3.0.CO;2-3","article-title":"Genetic pattern of prostate cancer progression","volume":"81","author":"Saric","year":"1999","journal-title":"International Journal of Cancer"},{"issue":"22","key":"10.1016\/j.suronc.2005.05.003_bib64","first-page":"5390","article-title":"Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer","volume":"55","author":"Macoska","year":"1995","journal-title":"Cancer Research"},{"issue":"13","key":"10.1016\/j.suronc.2005.05.003_bib65","first-page":"3091","article-title":"Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping","volume":"56","author":"Cher","year":"1996","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005392-199707000-00004","article-title":"The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues","volume":"158","author":"Haggman","year":"1997","journal-title":"Journal of Urology"},{"issue":"19","key":"10.1016\/j.suronc.2005.05.003_bib67","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1101\/gad.819500","article-title":"Molecular genetics of prostate cancer","volume":"14","author":"Abate-Shen","year":"2000","journal-title":"Genes & Development"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib68","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1097-0045(19990301)38:4<303::AID-PROS6>3.0.CO;2-E","article-title":"Chromosomal clues to the development of prostate tumors","volume":"38","author":"Brothman","year":"1999","journal-title":"Prostate"},{"issue":"7","key":"10.1016\/j.suronc.2005.05.003_bib69","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1073\/pnas.96.7.3928","article-title":"The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors","volume":"96","author":"Ishii","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/j.suronc.2005.05.003_bib70","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1101\/gad.13.8.966","article-title":"Roles for Nkx3.1 in prostate development and cancer","volume":"13","author":"Bhatia-Gaur","year":"1999","journal-title":"Genes & Development"},{"issue":"20","key":"10.1016\/j.suronc.2005.05.003_bib71","first-page":"4455","article-title":"Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers","volume":"57","author":"Voeller","year":"1997","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib72","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0022-5347(05)67867-6","article-title":"Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer","volume":"163","author":"Xu","year":"2000","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib73","first-page":"1","article-title":"Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas","volume":"144","author":"Chang","year":"1994","journal-title":"American Journal of Pathology"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.onc.1201554","article-title":"Identification of two distinct deleted regions on chromosome 13 in prostate cancer","volume":"16","author":"Li","year":"1998","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0046-8177(96)90134-3","article-title":"Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas","volume":"27","author":"Ittmann","year":"1996","journal-title":"Human Pathology"},{"key":"10.1016\/j.suronc.2005.05.003_bib76","unstructured":"Yeh S, Miyamoto H, Nishimura K, Kang H, Ludlow J, Hsiao P, et al. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells."},{"issue":"15","key":"10.1016\/j.suronc.2005.05.003_bib77","first-page":"3275","article-title":"Radiation-induced apoptosis mediated by retinoblastoma protein","volume":"58","author":"Bowen","year":"1998","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pros.2990210207","article-title":"Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas","volume":"21","author":"Sarkar","year":"1992","journal-title":"Prostate"},{"issue":"24","key":"10.1016\/j.suronc.2005.05.003_bib79","first-page":"5652","article-title":"Identification of 12p as a region of frequent deletion in advanced prostate cancer","volume":"58","author":"Kibel","year":"1998","journal-title":"Cancer Research"},{"issue":"12 Pt 1","key":"10.1016\/j.suronc.2005.05.003_bib80","first-page":"2269","article-title":"Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade","volume":"3","author":"Guo","year":"1997","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.suronc.2005.05.003_bib81","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jnci\/90.12.916","article-title":"Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma","author":"Cote","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.suronc.2005.05.003_bib82","article-title":"Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas","volume":"231\u2013234","author":"Loda","year":"1997","journal-title":"Nature Medicine"},{"key":"10.1016\/j.suronc.2005.05.003_bib83","unstructured":"Singh SP, Lipman J, Goldman H, Ellis Jr. FH, Aizenman L, Cangi MG, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma."},{"key":"10.1016\/j.suronc.2005.05.003_bib84","unstructured":"Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas."},{"issue":"6456","key":"10.1016\/j.suronc.2005.05.003_bib85","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib86","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0022-5347(01)64917-6","article-title":"Molecular analysis of the INK4 family of genes in prostate carcinomas","volume":"157","author":"Park","year":"1997","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib87","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V","article-title":"Deletional, mutational, and methylation analyses of CDKN2 (p16\/MTS1) in primary and metastatic prostate cancer","volume":"19","author":"Jarrard","year":"1997","journal-title":"Genes Chromosomes & Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1098-2744(199803)21:3<164::AID-MC3>3.0.CO;2-M","article-title":"Analysis of the p16 tumor suppressor gene in early stage prostate cancer","volume":"21","author":"Gu","year":"1998","journal-title":"Molecular Carcinogenesis"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib89","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1464-410x.1999.00953.x","article-title":"Neoadjuvant hormonal therapy in carcinoma of the prostate","volume":"83","author":"Lee","year":"1999","journal-title":"BJU International"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib90","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<416::AID-CNCR24>3.0.CO;2-#","article-title":"Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma","volume":"88","author":"Halvorsen","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F","article-title":"Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis","volume":"74","author":"Dong","year":"1997","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib92","first-page":"1891","article-title":"Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone","volume":"6","author":"Drobnjak","year":"2000","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1097-0045(19990101)38:1<40::AID-PROS5>3.0.CO;2-I","article-title":"Overexpression of cyclin D1 is rare in human prostate carcinoma","volume":"38","author":"Gumbiner","year":"1999","journal-title":"Prostate"},{"issue":"7","key":"10.1016\/j.suronc.2005.05.003_bib94","first-page":"1241","article-title":"Localization of potential tumor suppressor loci to a <2Mb region on chromosome 17q in human prostate cancer","volume":"11","author":"Gao","year":"1995","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib95","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0045(19990401)39:1<8::AID-PROS2>3.0.CO;2-N","article-title":"Prognostic value and expression of p21(waf1\/cip1) protein in prostate cancer","volume":"39","author":"Aaltomaa","year":"1999","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1097-0045(19990901)40:4<256::AID-PROS7>3.0.CO;2-I","article-title":"Relationship of p21(WAF1) expression with disease-free survival and biochemical recurrence in prostate adenocarcinomas (PCa)","volume":"40","author":"Sarkar","year":"1999","journal-title":"Prostate"},{"issue":"22","key":"10.1016\/j.suronc.2005.05.003_bib97","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.1073\/pnas.87.22.8751","article-title":"Allelic loss of chromosomes 16q and 10q in human prostate cancer","volume":"87","author":"Carter","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/gcc.2870080205","article-title":"Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis","volume":"8","author":"Macoska","year":"1993","journal-title":"Genes Chromosomes & Cancer"},{"issue":"12","key":"10.1016\/j.suronc.2005.05.003_bib99","first-page":"3273","article-title":"Allelic loss in locally metastatic, multisampled prostate cancer","volume":"54","author":"Sakr","year":"1994","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000019699","article-title":"Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men","volume":"34","author":"Madersbacher","year":"1998","journal-title":"European Urology"},{"issue":"22","key":"10.1016\/j.suronc.2005.05.003_bib101","first-page":"4997","article-title":"Frequent inactivation of PTEN\/MMAC1 in primary prostate cancer","volume":"57","author":"Cairns","year":"1997","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)80674-1","article-title":"The multiple roles of PTEN in tumor suppression","volume":"100","author":"Di Cristofano","year":"2000","journal-title":"Cell"},{"issue":"6684","key":"10.1016\/j.suronc.2005.05.003_bib103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/31008","article-title":"Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth","volume":"393","author":"Schreiber-Agus","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib104","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0897-333","article-title":"Germline mutations in PTEN are present in Bannayan\u2013Zonana syndrome","volume":"16","author":"Marsh","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1016\/j.suronc.2005.05.003_bib106","unstructured":"Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics."},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib107","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/84879","article-title":"Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse","volume":"27","author":"Di Cristofano","year":"2001","journal-title":"Nature Genetics"},{"issue":"15","key":"10.1016\/j.suronc.2005.05.003_bib108","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/sj.onc.1202119","article-title":"PTEN\/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate","volume":"17","author":"Dong","year":"1998","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.suronc.2005.05.003_bib109","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.onc.1200205","article-title":"Analysis of PTEN and the 10q23 region in primary prostate carcinomas","volume":"16","author":"Feilotter","year":"1998","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib110","first-page":"204","article-title":"Interfocal heterogeneity of PTEN\/MMAC1 gene alterations in multiple metastatic prostate cancer tissues","volume":"58","author":"Suzuki","year":"1998","journal-title":"Cancer Research"},{"issue":"20","key":"10.1016\/j.suronc.2005.05.003_bib111","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.201167798","article-title":"Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression","volume":"98","author":"Kwabi-Addo","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.suronc.2005.05.003_bib112","unstructured":"Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR."},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib113","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ng0395-249","article-title":"Mutation of the MXI1 gene in prostate cancer","volume":"9","author":"Eagle","year":"1995","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib114","first-page":"803","article-title":"Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays","volume":"59","author":"Bubendorf","year":"1999","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.0.CO;2-Q","article-title":"Commonly occurring loss and mutation of the MXI1 gene in prostate cancer","volume":"22","author":"Prochownik","year":"1998","journal-title":"Genes Chromosomes & Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib116","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1097-0045(199609)29:3<191::AID-PROS2990290305>3.0.CO;2-1","article-title":"Point mutations of the Mxil gene are rare in prostate cancers","volume":"29","author":"Kawamata","year":"1996","journal-title":"Prostate"},{"issue":"19","key":"10.1016\/j.suronc.2005.05.003_bib117","first-page":"6130","article-title":"Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture","volume":"50","author":"Fidler","year":"1990","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib118","first-page":"1273","article-title":"A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans","volume":"4","author":"Cher","year":"1998","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib119","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.bjc.6690025","volume":"79","author":"Elo","year":"1999","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1098-2264(199612)17:4<225::AID-GCC4>3.0.CO;2-5","article-title":"Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers","volume":"17","author":"Suzuki","year":"1996","journal-title":"Genes Chromosomes & Cancer"},{"issue":"22","key":"10.1016\/j.suronc.2005.05.003_bib121","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1038\/sj.onc.1202081","article-title":"PTEN\/MMAC1\/TEP1 involvement in primary prostate cancers","volume":"16","author":"Pesche","year":"1998","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.suronc.2005.05.003_bib122","first-page":"3189","article-title":"Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival","volume":"57","author":"Richmond","year":"1997","journal-title":"Cancer Research"},{"issue":"14","key":"10.1016\/j.suronc.2005.05.003_bib123","first-page":"3929","article-title":"Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer","volume":"54","author":"Umbas","year":"1994","journal-title":"Cancer Research"},{"issue":"5000","key":"10.1016\/j.suronc.2005.05.003_bib124","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.2006419","article-title":"Cadherin cell adhesion receptors as a morphogenetic regulator","volume":"251","author":"Takeichi","year":"1991","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.suronc.2005.05.003_bib125","first-page":"2520","article-title":"Beta-catenin mutations in human prostate cancer","volume":"58","author":"Voeller","year":"1998","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W","article-title":"Detection and analysis of beta-catenin mutations in prostate cancer","volume":"45","author":"Chesire","year":"2000","journal-title":"Prostate"},{"issue":"5015","key":"10.1016\/j.suronc.2005.05.003_bib127","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/er.20.1.22","article-title":"Molecular genetics and epidemiology of prostate carcinoma","volume":"20","author":"Ruijter","year":"1999","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.suronc.2005.05.003_bib129","first-page":"119","article-title":"Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer","volume":"77","author":"Castagnaro","year":"1993","journal-title":"Verhandlungen der Deutschen Gesellschaft fuer Pathologie"},{"issue":"16","key":"10.1016\/j.suronc.2005.05.003_bib130","first-page":"3814","article-title":"An uncertain role for p53 gene alterations in human prostate cancers","volume":"56","author":"Brooks","year":"1996","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib131","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5347(17)35000-0","article-title":"p53 oncogene mutations in human prostate cancer specimens","volume":"151","author":"Voeller","year":"1994","journal-title":"Journal of Urology"},{"issue":"20","key":"10.1016\/j.suronc.2005.05.003_bib132","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/jnci\/85.20.1657","article-title":"p53 protein accumulation and gene mutation in the progression of human prostate carcinoma","volume":"85","author":"Navone","year":"1993","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib133","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0022-5347(17)35231-X","article-title":"Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma","volume":"151","author":"Aprikian","year":"1994","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib134","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00019606-199612000-00008","article-title":"Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay","volume":"5","author":"Shi","year":"1996","journal-title":"Diagnostic Molecular Pathology"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib135","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0022-5347(01)61646-X","article-title":"Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy","volume":"161","author":"Brewster","year":"1999","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib136","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0022-5347(05)68095-0","article-title":"p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy","volume":"162","author":"Stackhouse","year":"1999","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib137","first-page":"1","article-title":"Tumors associated with p53 germline mutations: a synopsis of 91 families","volume":"150","author":"Kleihues","year":"1997","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.suronc.2005.05.003_bib138","first-page":"1","article-title":"Prognostic factors in prostate cancer","volume":"185","author":"Stattin","year":"1997","journal-title":"Scandinavian Journal of Urology and Nephrology Supplement"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib139","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0022-5347(01)66165-2","article-title":"p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma","volume":"155","author":"Prendergast","year":"1996","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jnci\/89.2.158","article-title":"p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610","volume":"89","author":"Grignon","year":"1997","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib141","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-4295(97)00636-5","article-title":"p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy","volume":"51","author":"Huang","year":"1998","journal-title":"Urology"},{"issue":"6907","key":"10.1016\/j.suronc.2005.05.003_bib142","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"issue":"6680","key":"10.1016\/j.suronc.2005.05.003_bib143","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/30012","article-title":"Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells","volume":"393","author":"Qiu","year":"1998","journal-title":"Nature"},{"issue":"4 Suppl 12","key":"10.1016\/j.suronc.2005.05.003_bib144","first-page":"89","article-title":"Combination therapy with trastuzumab (Herceptin) and cisplatin for chemoresistant metastatic breast cancer: evidence for receptor-enhanced chemosensitivity","volume":"26","author":"Pegram","year":"1999","journal-title":"Seminars in Oncology"},{"issue":"23","key":"10.1016\/j.suronc.2005.05.003_bib145","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jnci\/92.23.1866","article-title":"HER2 in prostate cancer\u2014a viable target or innocent bystander?","volume":"92","author":"Scher","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"issue":"19","key":"10.1016\/j.suronc.2005.05.003_bib146","first-page":"4761","article-title":"Response of prostate cancer to anti-Her-2\/neu antibody in androgen-dependent and -independent human xenograft models","volume":"59","author":"Agus","year":"1999","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib147","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/6495","article-title":"A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2\/neu tyrosine kinase","volume":"5","author":"Craft","year":"1999","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/j.suronc.2005.05.003_bib148","first-page":"1045","article-title":"Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers","volume":"3","author":"Yu","year":"1997","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib149","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1083\/jcb.108.6.2435","article-title":"Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell\u2013cell adhesion","volume":"108","author":"Behrens","year":"1989","journal-title":"Journal of Cell Biology"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib150","first-page":"846","article-title":"CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13","volume":"57","author":"Gao","year":"1997","journal-title":"Cancer Research"},{"issue":"5212","key":"10.1016\/j.suronc.2005.05.003_bib151","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.7754374","article-title":"KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2","volume":"268","author":"Dong","year":"1995","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib152","first-page":"805","article-title":"The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy","volume":"3","author":"Noordzij","year":"1997","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.suronc.2005.05.003_bib153","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4899-1813-0_7","article-title":"Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications","volume":"407","author":"Gao","year":"1997","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib154","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1098-2264(199710)20:2<140::AID-GCC4>3.0.CO;2-3","article-title":"Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer","volume":"20","author":"Ueda","year":"1997","journal-title":"Genes Chromosomes & Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0197-2456(94)00XXX-M","article-title":"Design of the Prostate Cancer Prevention Trial (PCPT)","volume":"16","author":"Feigl","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1016\/j.suronc.2005.05.003_bib156","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"9306","key":"10.1016\/j.suronc.2005.05.003_bib157","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.suronc.2005.05.003_bib158","first-page":"3550","article-title":"Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer","volume":"61","author":"Linja","year":"2001","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib159","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib160","first-page":"314","article-title":"Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer","volume":"57","author":"Koivisto","year":"1997","journal-title":"Cancer Research"},{"issue":"13","key":"10.1016\/j.suronc.2005.05.003_bib161","first-page":"3623","article-title":"Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer","volume":"60","author":"Kinoshita","year":"2000","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib162","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/en.135.4.1359","article-title":"Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation","volume":"135","author":"Ikonen","year":"1994","journal-title":"Endocrinology"},{"issue":"21","key":"10.1016\/j.suronc.2005.05.003_bib163","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199505253322101","article-title":"Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer","volume":"332","author":"Taplin","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib164","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<559::AID-PATH471>3.0.CO;2-Y","article-title":"Androgen receptor gene mutations in hormone-refractory prostate cancer","volume":"189","author":"Wallen","year":"1999","journal-title":"Journal of Pathology"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-5347(01)65204-2","article-title":"Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer","volume":"157","author":"McDonnell","year":"1997","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1016\/j.suronc.2005.05.003_bib166","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0090-4295(98)00360-4","article-title":"bcl-2\/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer","volume":"52","author":"Mackey","year":"1998","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.suronc.2005.05.003_bib167","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0022-5347(01)66765-X","article-title":"Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies","volume":"154","author":"Tu","year":"1995","journal-title":"Journal of Urology"},{"issue":"11\u201312","key":"10.1016\/j.suronc.2005.05.003_bib168","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/sj.bjc.6690264","article-title":"Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells","volume":"79","author":"Miyake","year":"1999","journal-title":"British Journal of Cancer"},{"issue":"10","key":"10.1016\/j.suronc.2005.05.003_bib169","first-page":"2891","article-title":"Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model","volume":"5","author":"Gleave","year":"1999","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9440(10)65554-X","article-title":"Genetic alterations in hormone-refractory recurrent prostate carcinomas","volume":"153","author":"Nupponen","year":"1998","journal-title":"American Journal of Pathology"},{"issue":"18","key":"10.1016\/j.suronc.2005.05.003_bib171","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/jnci\/91.18.1574","article-title":"Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma","volume":"91","author":"Sato","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.suronc.2005.05.003_bib172","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<95::AID-GCC12>3.0.CO;2-3","article-title":"Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer","volume":"27","author":"Reiter","year":"2000","journal-title":"Genes Chromosomes & Cancer"},{"issue":"6871","key":"10.1016\/j.suronc.2005.05.003_bib173","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"\u2018t Veer","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.suronc.2005.05.003_bib174","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/gcc.2870140402","article-title":"Genetic alterations in breast cancer","volume":"14","author":"Bieche","year":"1995","journal-title":"Genes Chromosomes & Cancer"},{"issue":"2","key":"10.1016\/j.suronc.2005.05.003_bib175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1535-6108(02)00030-2","article-title":"Gene expression correlates of clinical prostate cancer behavior","volume":"1","author":"Singh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.suronc.2005.05.003_bib176","first-page":"5974","article-title":"Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer","author":"Welsh","year":"2001","journal-title":"Cancer Research"},{"issue":"6769","key":"10.1016\/j.suronc.2005.05.003_bib177","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"6795","key":"10.1016\/j.suronc.2005.05.003_bib178","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/35020115","article-title":"Molecular classification of cutaneous malignant melanoma by gene expression profiling","volume":"406","author":"Bittner","year":"2000","journal-title":"Nature"},{"issue":"6797","key":"10.1016\/j.suronc.2005.05.003_bib179","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740405000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740405000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T02:32:52Z","timestamp":1551666772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740405000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":179,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0960740405000228"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2005.05.003","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}